TREM2 and Alzheimer disease: Genome-wide association studies (GWAS) have identified >30 AD genetic risk loci, many of which appear to be related to innate immunity and microglial function, including APOE and TREM2 variants, which are associated with high genetic risks for sporadic AD [6–10].